Medical Device Approvals Keep Stocks Up
607304
Food and Drug Administration approvals kept medical device and drug company stocks in the spotlight with two device companies reporting product approvals Wednesday.
697549
New drug prospects push shares to a new 52-week high.
169862
U.S. stocks should maintain their 3 1/2-year highs next week as they ring out 2004, helped by investor interest in large-cap stocks and a steady rebound in beaten-down drug companies.
330243
Investors are keeping an eye on sequential numbers.
596681
These high-quality stocks have the wind at their back.
751523
A new addition to an already successful drug promises good results for investors.
632549
The Dow and S&P rose on Monday, led by health-care and consumer staple shares, as investors poured into companies seen best able to withstand an economic slowdown following dismal employment data last Friday.
428440
Impressive earnings drive the medical device maker to a 52-week high.
610716
The No. 3 cardiology company posts solid growth because of continuing ICD market share gains.
655254
U.S. stocks rose on Wednesday as value  investors bought shares in lagging sectors such as healthcare,  while oil prices slipped below $42 a barrel.
40020
Not everyone wants the market to keep going up.
494835
Shares of drug company AtheroGenics Inc. opened up 81 percent Tuesday morning and remained at high levels after the company revealed promising clinical data late Monday for a drug to treat hardening arteries.
557154
U.S. stocks held solid gains on  Wednesday, as oil prices held below $42 a barrel and healthcare  stocks rose, with shares of drugmaker Merck & Co. MRK.N up  after issuing a 2005 forecast that was better than some  analysts had expected.
538504
Health care company raises earnings guidance, but its vital signs bear watching.
693188
U.S. stocks rose on Wednesday, helped by shares of health and defense companies that are expected to benefit from the re-election of President Bush, but higher oil prices checked advances.
462759
Medtronic Inc. (MDT.N) on Wednesday said its quarterly earnings rose on brisk demand for devices that manage irregular heart beats and products used to treat the spine.
652440
The FTSE 100 has climbed as a surge by US shares gives a boost to European markets. Shire Pharmaceuticals SHP.L jumped after winning approval for a key drug and consumer goods giant Unilever ULVR.